U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Wed Apr 02 09:45:18 GMT 2025
Edited
by admin
on Wed Apr 02 09:45:18 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
VXQ2SK8I3P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BIRTAMIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN SERUM AMYLOID A PROTEIN/IMMUNOGLOBULIN AL (AMYLOID LIGHT-CHAIN)) (HUMAN-MUS MUSCULUS MONOCLONAL NEOD001 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL NEOD001 .KAPPA.-CHAIN, DIMER
Preferred Name English
HU2A4
Code English
birtamimab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN SERUM AMYLOID PROTEIN A-1 (SAA))
Systematic Name English
ELT1-01
Code English
BIRTAMIMAB [USAN]
Common Name English
NEOD001
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
FDA ORPHAN DRUG 361411
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C142958
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
PRIMARY
FDA UNII
VXQ2SK8I3P
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
PRIMARY
CAS
1608108-91-3
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
PRIMARY
INN
10198
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
PRIMARY
USAN
BC-154
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
PRIMARY
SMS_ID
100000183554
Created by admin on Wed Apr 02 09:45:18 GMT 2025 , Edited by admin on Wed Apr 02 09:45:18 GMT 2025
PRIMARY
From To
1_22 1_98
1_146 1_202
1_263 1_323
1_369 1_427
2_22 2_98
2_146 2_202
2_263 2_323
2_369 2_427
1_222 3_219
2_222 4_219
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
1_228 2_228
1_231 2_231
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_299
N 2_299
Related Record Type Details
BIRTAMIMAB
ACTIVE MOIETY
immunomodulator
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966